Date:12/11/2008 URL: http://www.thehindu.com/2008/11/12/stories/2008111256771700.htm

Business - Briefly

Lupin launches IVABRAD

CHENNAI: Lupin has received the Drug Controller General of India (DCGI) approval to launch India’s first selective and specific sinus node of channel inhibitor; IVABRAD (Ivabradine) which is now available in 5 mg and 7.5 mg tablets. IVABRAD comes from Pinnacle, Lupin’s marketing division for specialty drugs in India, according to a release.